Powder: -20°C for 3 years | In solvent: -80°C for 1 year
XL092 (JUN04542) is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 51.00 | |
5 mg | In stock | $ 122.00 | |
10 mg | In stock | $ 197.00 | |
25 mg | In stock | $ 455.00 | |
50 mg | In stock | $ 672.00 | |
100 mg | In stock | $ 956.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 142.00 |
Description | XL092 (JUN04542) is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders. |
Targets&IC50 | MET:15 nM (IC50), Mer:7.2 nM (IC50), Axl:3.4 nM (IC50), VEGFR2:1.6 nM (IC50) |
Synonyms | CL-092, JUN04542 |
Molecular Weight | 528.53 |
Formula | C29H25FN4O5 |
CAS No. | 2367004-54-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.29 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
XL092 2367004-54-2 Angiogenesis Tyrosine Kinase/Adaptors TAM Receptor c-Met/HGFR VEGFR Axl XL-092 CL-092 JUN04542 Vascular endothelial growth factor receptor p-MET p-VEGFR2 Mer ATP Inhibitor CL 092 JUN 04542 Tyro3 CL092 orally XL 092 inhibit JUN-04542 inhibitor